Clover Health Investments Statistics
Total Valuation
CLOV has a market cap or net worth of $1.39 billion. The enterprise value is $1.29 billion.
Important Dates
The next confirmed earnings date is Wednesday, May 6, 2026, after market close.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CLOV has 524.67 million shares outstanding. The number of shares has increased by 4.48% in one year.
| Current Share Class | 428.95M |
| Shares Outstanding | 524.67M |
| Shares Change (YoY) | +4.48% |
| Shares Change (QoQ) | +0.88% |
| Owned by Insiders (%) | 22.16% |
| Owned by Institutions (%) | 23.98% |
| Float | 404.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 29.18 |
| PS Ratio | 0.71 |
| Forward PS | 0.46 |
| PB Ratio | 4.24 |
| P/TBV Ratio | 4.45 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.67 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.47, with a Debt / Equity ratio of 0.01.
| Current Ratio | 1.47 |
| Quick Ratio | 1.34 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -26.33% and return on invested capital (ROIC) is -16.37%.
| Return on Equity (ROE) | -26.33% |
| Return on Assets (ROA) | -9.53% |
| Return on Invested Capital (ROIC) | -16.37% |
| Return on Capital Employed (ROCE) | -25.75% |
| Weighted Average Cost of Capital (WACC) | 16.59% |
| Revenue Per Employee | $2.66M |
| Profits Per Employee | -$118,162 |
| Employee Count | 724 |
| Asset Turnover | 3.43 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.03% in the last 52 weeks. The beta is 2.25, so CLOV's price volatility has been higher than the market average.
| Beta (5Y) | 2.25 |
| 52-Week Price Change | -23.03% |
| 50-Day Moving Average | 2.03 |
| 200-Day Moving Average | 2.54 |
| Relative Strength Index (RSI) | 78.86 |
| Average Volume (20 Days) | 5,714,608 |
Short Selling Information
The latest short interest is 40.58 million, so 7.74% of the outstanding shares have been sold short.
| Short Interest | 40.58M |
| Short Previous Month | 39.12M |
| Short % of Shares Out | 7.74% |
| Short % of Float | 10.02% |
| Short Ratio (days to cover) | 7.14 |
Income Statement
In the last 12 months, CLOV had revenue of $1.92 billion and -$85.55 million in losses. Loss per share was -$0.17.
| Revenue | 1.92B |
| Gross Profit | 355.10M |
| Operating Income | -85.53M |
| Pretax Income | -85.55M |
| Net Income | -85.55M |
| EBITDA | -85.34M |
| EBIT | -85.53M |
| Loss Per Share | -$0.17 |
Full Income StatementBalance Sheet
The company has $120.26 million in cash and $3.30 million in debt, giving a net cash position of $75.01 million or $0.14 per share.
| Cash & Cash Equivalents | 120.26M |
| Total Debt | 3.30M |
| Net Cash | 75.01M |
| Net Cash Per Share | $0.14 |
| Equity (Book Value) | 308.70M |
| Book Value Per Share | 0.59 |
| Working Capital | 99.03M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$66.93 million and capital expenditures -$2.04 million, giving a free cash flow of -$68.98 million.
| Operating Cash Flow | -66.93M |
| Capital Expenditures | -2.04M |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -68.98M |
| FCF Per Share | -$0.13 |
Full Cash Flow StatementMargins
Gross margin is 18.46%, with operating and profit margins of -4.45% and -4.45%.
| Gross Margin | 18.46% |
| Operating Margin | -4.45% |
| Pretax Margin | -4.45% |
| Profit Margin | -4.45% |
| EBITDA Margin | -4.44% |
| EBIT Margin | -4.45% |
| FCF Margin | n/a |